BioPharmSignal logoBioPharmSignal

Biotech News

AtriCure to Announce First Quarter 2026 Financial Results

AtriCure (ATRC)AtriCureEarnings

MASON, Ohio --(BUSINESS WIRE)--Apr. 14, 2026-- AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter

Open original release

Related news

ATRCAtriCure2026-05-05 20:01 EST

AtriCure Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

HYPRHyperfine2026-04-28 20:05 EST

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

XTNTXtant Medical2026-03-25 12:00 EST

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

PAVMPAVmed2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

HYPRHyperfine2026-05-12 20:05 EST

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

CVRXCVRx2026-05-11 20:05 EST

CVRx Reports First Quarter 2026 Financial and Operating Results

TMCITreace Medical Concepts2026-05-08 11:05 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

View all latest news

AtriCure

AtriCure is a surgical device company focused on atrial fibrillation, left atrial appendage management, and cardiac ablation.

Recent company news

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

ATRCAtriCure2026-05-05 20:01 EST

AtriCure Reports First Quarter 2026 Financial Results

ATRCAtriCure2026-04-28 12:00 EST

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

ATRCAtriCure2026-04-14 12:00 EST

AtriCure to Announce First Quarter 2026 Financial Results

ATRCAtriCure2026-02-24 13:00 EST

AtriCure to Participate in the Citizens Life Sciences Conference

Stock data

Close
37.37 USD
Market cap
1.31B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States